N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide

C45H52F7N9O5 — CID 160686498

IUPACN-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide
SMILESCCOCCCNC(=O)c1ccc(N2CCN(C(=O)c3ccc(C(F)(F)F)cc3)CC2)nc1.CN(C)CCCNC(=O)c1ccc(N2CCN(C(=O)c3cc(F)c(F)c(F)c3F)CC2)nc1
InChIInChI=1S/C23H27F3N4O3.C22H25F4N5O2/c1-2-33-15-3-10-27-21(31)18-6-9-20(28-16-18)29-11-13-30(14-12-29)22(32)17-4-7-19(8-5-17)23(24,25)26;1-29(2)7-3-6-27-21(32)14-4-5-17(28-13-14)30-8-10-31(11-9-30)22(33)15-12-16(23)19(25)20(26)18(15)24/h4-9,16H,2-3,10-15H2,1H3,(H,27,31);4-5,12-13H,3,6-11H2,1-2H3,(H,27,32)
InChIKeyROVHFEIHZGERCJ-UHFFFAOYSA-N
MW931.95 g/mol
LogP5.50
Rot. Bonds15

About N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide

N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide (PubChem CID 160686498) has the molecular formula C45H52F7N9O5 and a molecular weight of 931.95 g/mol. Its IUPAC name is N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide.

Molecular Properties

Compound NameN-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide
PubChem CID160686498
Molecular FormulaC45H52F7N9O5
Molecular Weight931.95 g/mol
Exact Mass931.40
IUPAC NameN-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide
SMILESCCOCCCNC(=O)c1ccc(N2CCN(C(=O)c3ccc(C(F)(F)F)cc3)CC2)nc1.CN(C)CCCNC(=O)c1ccc(N2CCN(C(=O)c3cc(F)c(F)c(F)c3F)CC2)nc1
InChIInChI=1S/C23H27F3N4O3.C22H25F4N5O2/c1-2-33-15-3-10-27-21(31)18-6-9-20(28-16-18)29-11-13-30(14-12-29)22(32)17-4-7-19(8-5-17)23(24,25)26;1-29(2)7-3-6-27-21(32)14-4-5-17(28-13-14)30-8-10-31(11-9-30)22(33)15-12-16(23)19(25)20(26)18(15)24/h4-9,16H,2-3,10-15H2,1H3,(H,27,31);4-5,12-13H,3,6-11H2,1-2H3,(H,27,32)
InChIKeyROVHFEIHZGERCJ-UHFFFAOYSA-N
XLogP5.50
TPSA143.55 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds15
Heavy Atoms66
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500931.95
LogP ≤ 55.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_2', 'substructure': 'N/A'}

Analyze N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide?
The IUPAC name of N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide (CID 160686498) is N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide.
What is the SMILES notation for N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide?
The canonical SMILES for N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide is CCOCCCNC(=O)c1ccc(N2CCN(C(=O)c3ccc(C(F)(F)F)cc3)CC2)nc1.CN(C)CCCNC(=O)c1ccc(N2CCN(C(=O)c3cc(F)c(F)c(F)c3F)CC2)nc1.
What is the InChIKey of N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide?
The InChIKey is ROVHFEIHZGERCJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H27F3N4O3.C22H25F4N5O2/c1-2-33-15-3-10-27-21(31)18-6-9-20(28-16-18)29-11-13-30(14-12-29)22(32)17-4-7-19(8-5-17)23(24,25)26;1-29(2)7-3-6-27-21(32)14-4-5-17(28-13-14)30-8-10-31(11-9-30)22(33)15-12-16(23)19(25)20(26)18(15)24/h4-9,16H,2-3,10-15H2,1H3,(H,27,31);4-5,12-13H,3,6-11H2,1-2H3,(H,27,32).
What are the key properties of N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide?
N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide has a molecular weight of 931.95 g/mol, XLogP of 5.50, 15 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(dimethylamino)propyl]-6-[4-(2,3,4,5-tetrafluorobenzoyl)piperazin-1-yl]pyridine-3-carboxamide;N-(3-ethoxypropyl)-6-[4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxamide is sourced from PubChem (CID 160686498), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).